Lecture

Catalysis: Mechanisms and Case Studies

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

In course

CH-223: Organometallic chemistry

Basic organometallic chemistry will be covered in this course.

Structure and bonding in organometallic compounds.
reactivity of organometallic compounds, stoichiometric reactions, catalyzed reactions and reaction mechanisms. ...

Description

This lecture covers the fundamentals of catalysis, including activity, selectivity, reaction conditions, stability, and catalyst separation. Two important reactions, hydrogenation using Wilkinson catalyst and carbonylation in the Monsanto process, are studied in detail.

Instructors (2)

Marinella Mazzanti

Expertise Inorganic Chemistry, Coordination ChemistryF-elements Chemistry Teaching & PhD Past EPFL PhD Students Julie Renée Michelle Andrez, Marta Falcone, Radmila Faizova, Davide Toniolo, Luciano Barluzzi, Aurélien René Willauer, Nadir Jori, Dieuwertje Katelijn Modder, Hsueh Fang-Che, Keerthi Shivaraam Rangaraj Ananthakumar, Mikhail Batov Past EPFL PhD Students as codirector Andreichenko Andrei Courses Chemistry of f elements CH-427 The course will provide a synopsis of the chemistry of f e

Felix Daniel Bobbink

Official source

Ontological neighbourhood

Chemistry

Organic chemistry: Organometallic chemistry

Related concepts (32)

Homogeneous catalysis

In chemistry, homogeneous catalysis is catalysis where the catalyst is in same phase as reactants, principally by a soluble catalyst a in solution. In contrast, heterogeneous catalysis describes processes where the catalysts and substrate are in distinct phases, typically solid-gas, respectively. The term is used almost exclusively to describe solutions and implies catalysis by organometallic compounds. Homogeneous catalysis is an established technology that continues to evolve.

Rh blood group system

The Rh blood group system is a human blood group system. It contains proteins on the surface of red blood cells. After the ABO blood group system, it is the most likely to be involved in transfusion reactions. The Rh blood group system consisted of 49 defined blood group antigens in 2005. As of 2023, there are over 50 antigens among which the five antigens D, C, c, E, and e are the most important. There is no d antigen. Rh(D) status of an individual is normally described with a positive (+) or negative (−) suffix after the ABO type (e.

Rh disease

Rh disease (also known as rhesus isoimmunization, Rh (D) disease, and blue baby disease) is a type of hemolytic disease of the fetus and newborn (HDFN). HDFN due to anti-D antibodies is the proper and currently used name for this disease as the Rh blood group system actually has more than 50 antigens and not only the D-antigen. The term "Rh Disease" is commonly used to refer to HDFN due to anti-D antibodies, and prior to the discovery of anti-Rho(D) immune globulin, it was the most common type of HDFN.

Blood type

A blood type (also known as a blood group) is a classification of blood, based on the presence and absence of antibodies and inherited antigenic substances on the surface of red blood cells (RBCs). These antigens may be proteins, carbohydrates, glycoproteins, or glycolipids, depending on the blood group system. Some of these antigens are also present on the surface of other types of cells of various tissues. Several of these red blood cell surface antigens can stem from one allele (or an alternative version of a gene) and collectively form a blood group system.

Rho(D) immune globulin

Rho(D) immune globulin (RhIG) is a medication used to prevent RhD isoimmunization in mothers who are RhD negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when RhD-negative people are given RhD-positive blood. It is given by injection into muscle or a vein. A single dose lasts 12 weeks. It is made from human blood plasma. Common side effects include fever, headache, pain at the site of injection, and red blood cell breakdown.

Related lectures (64)

Organometallic Reactions

Covers main organometallic reactions and factors driving them, with exercises predicting reaction products.

Catalysis: Hydrogenation

Covers the topic of catalysis, focusing on the process of hydrogenation and the advantages of using soluble catalysts.

Catalysis: History and Modern Challenges

Explores the history of catalysis, Nobel Prizes in the field, types of catalysis, and modern challenges.

Publication Analysis: Understanding Research Articles

Introduces publication analysis, emphasizing critical evaluation of research articles and effective reading strategies.

Homogeneous Catalysis Basics